Unmet needs and opportunities for optimal management of patients with type 2 diabetes and chronic kidney disease

Kevin M Pantalone; Xinge Ji; Sheldon X Kong; Jay C Elliott; Alex Milinovich; Anita D Misra-Hebert; Ryan Farej; Rakesh Singh; Janine M Bauman; Robert S Zimmerman; Tushar J Vachharajani; Jamie Partridge; Jennifer Cameron; Todd Williamson; Michael W Kattan

doi:10.1016/j.jdiacomp.2023.108418

Unmet needs and opportunities for optimal management of patients with type 2 diabetes and chronic kidney disease

J Diabetes Complications. 2023 Apr;37(4):108418. doi: 10.1016/j.jdiacomp.2023.108418. Epub 2023 Feb 13.

Authors

Affiliations

¹ Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, OH 44195, United States of America. Electronic address: [email protected].
² Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH 44195, United States of America.
³ Bayer US LLC, Whippany, NJ, 07981, United States of America.
⁴ Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH 44195, United States of America; Department of Internal Medicine, Cleveland Clinic Community Care, Cleveland Clinic, Cleveland, OH 44195, United States of America; Healthcare Delivery & Implementation Science Center, Cleveland Clinic, Cleveland, OH 44195, United States of America.
⁵ Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, OH 44195, United States of America.
⁶ Glickman Urologiceal & Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, United States of America.

PMID: 36848798
DOI: 10.1016/j.jdiacomp.2023.108418

Abstract

This brief report utilizes EHR data from a large US health system to summarize unmet needs in patients with type 2 diabetes and chronic kidney disease and identifies areas of opportunity to optimize management within this patient population from treatment, screening and monitoring, and health care resource use perspectives.

Keywords: CKD; Chronic kidney disease; Healthcare costs; Healthcare resource utilization; T2D; Type 2 diabetes.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Diabetes Mellitus, Type 2* / complications
Diabetes Mellitus, Type 2* / epidemiology
Diabetes Mellitus, Type 2* / therapy
Humans
Renal Insufficiency, Chronic* / complications
Renal Insufficiency, Chronic* / epidemiology
Renal Insufficiency, Chronic* / therapy